Abbott Contract Manufacturing and Active Pharmaceutical Ingredients
Contract Manufacturing and Active Pharmaceutical Ingredients A Promise for Life
Home | Site Map | Contact Us
go
 
 

Home

Contract Manufacturing

Active Pharmaceutical Ingredients
  • Product Listing
      – Active Pharmaceutical Ingredients
      Fine Pharmaceuticals
     – Amezinium Methylsulfate
     – Biperiden Base
     – Biperiden Hydrochloride
     – Butorphanol
     – Cyclosporine
     – Enflurane
     – Gallopamil Hydrochloride
     – Isoflurane
     – Levobupivacaine Hydrochloride
     – Levothyroxine Na
     – Pramoxine Hydrochloride
     – Propafenone Hydrochloride
     – Proscillaridin 
     – Selenium Sulfide
     – Sodium Divalproex
     – Verapamil Hydrochloride    		  Antibiotics
     – Clarithromycin 
     – Clindamycin Phosphate
     – Erythromycin Base
     – Erythromycin Ethylsuccinate
     – Erythromycin Stearate
     – Erythromycin Thiocyanate
     – Vancomycin Hydrochloride
  • Clindamycin Phosphate
  • Pramoxine
  • Product Data Inquiry
      – Sample Request
      – MSDS
      – Certificate of Analysis
      – TSE/BSE Statement
      – Residual Solvent Statement
      – Abbott GMP Certification
      – Brochure
  • Lactulose
  • Customer Service
      – E-mail: bulkpharma@abbott.com
      – Phone: 1-800-240-1043

Locations

Plant Presentations

Frequently Asked Questions

News and Events

  • Technical Presentations
  –

American Pharmaceutical Review, (APR) Ralph Lambalot, Single-Use Disposable Technologies in Biopharmaceutical Contract Manufacturing
  – Life Science Leader, (LSL) Barry Regan, Solid-Dose Pharma Manufacturing Roundtable
  –

Genetic Pharma News
  – Pharma Tech – June Potent
  – Process Qualification – Linking C&Q to Process Validation
  – Operational Strategies for Lean Sigma Manufacturing
  – Selection, Design and Risk Based Qualification of a Tablet Coater for the Development and Launch of Highly Potent Compounds
  – Achieving process robustness through Process Analytical Technology implementation
  – Analyzing Physical Barriers in Antibody Manufacturing
  – Comparison of cell culture product quality at development and manufacturing scales
  – Developing and Enhancing Partnerships through Continuous Improvement
  – Kinetic and Functional Studies of Charge and Size Variants in Recombinant Monoclonal Antibodies
  – Process analytical technology (PAT) and data management to control product quality
  – Commissioning and Qualification - An Example of a Hybrid Approach
  – The Hour of Particle (Pharm Tech)
  – Resistant Bugs Necessitate Tougher Tactics (GEN)
  • Technical Papers
  – Disposables in Clinical Manufacturing

Licensing

Brochure

Contact Us

Come See Us at:
  • Next Level Pharma
    Biologics Manufacturing Outsourcing Partnerships
    February 1-2
    Munich, Germany
  • IBC
    Feb. 29 - Mar. 2
    Hilton San Diego, Bayfront Hotel,
    San Diego, California, U.S.A.
  • DCAT
    March 12-15
    Waldorf-Astoria Hotel
    Suite: 14A
    New York, New York,
    U.S.A.
  • CPhI Japan
    March 21 -23
    Tokyo Big Sight,
    Tokyo Japan

Abbott Global


 

 
 

Home | Privacy Policy | Terms of Use
© 2011 Abbott Laboratories.